Tech Update: Perceval Sutureless Aortic Valve Replacement Gets CE Mark For Extended Indications
By Adam Pick on October 1, 2012
In case you missed it… The Sorin Group, a leading manufacturer of heart valve replacement devices, recently announced that its Perceval Sutureless Heart Valve Replacement device received a CE Mark for extended indications in Europe.
Prior to this announcement, the Perceval was limited to patients who were 75 years or older. Now, the Perceval can be used on patients with severe aortic stenosis that are over the age of 65.
If this is your first time hearing of the Perceval sutureless aortic valve replacement device, you may want to know the following:
- The valve is “sutureless” which means it does not need to be stitched into the heart
- To maintain its position in the heart, the Perceval uses “self-anchors” shown above
- The valve is made the tissue of a cow
- Because the valve is sutureless, the procedure time is reduced thereby minimizing the patient time on the heart lung machine
For those of you in the United States, please note that Perceval valve replacement is not currently approved by the FDA. However, as I learned in this video with Dr. Eric Roselli at the Cleveland Clinic, the valve is currently being evaluated in clinical studies.
As a technology enthusiast, I will continue to monitor the latest devices that are enhancing valvular therapy. If you would like to learn more, simply sign up to my free newsletter by clicking this link.
Keep on tickin!